Description
Created On: 2020-07-15
Record Count: 4
Primary Industries
- Drugs
- Diagnostic
- Biotechnology
- Respiratory
- ribonucleic acid
- Device
- Disease
- DNA
IPSCIO Report Record List
Below you will find the records curated into this collection. This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs. The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms. For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report
IPSCIO Record ID: 27234
Patent No. 5,168,053
IPSCIO Record ID: 245871
US 4,987,071 – RNA Ribozyme Polymerases, Dephosphorylases, Restriction Endoribonucleases and Methods
US 5,037,746 – RNA Ribozyme Polymerases and Methods
US 5,093,246 – RNA Ribozyme Polymerases, Dephosphorylases, Restriction Endoribonucleases and Methods
Ribozyme shall mean a nucleic acid molecule capable of catalyzing reactions including, but not limited to, site-specific cleavage and/or ligation of other nucleic acid molecules, cleavage of peptide and amide bonds, polymerization and transsplicing.
Ribozymes For Research shall mean Ribozymes required by Licensee for purposes of research and development of a Semi-finished Product, Product or Licensed Service, including those required under a Work Plan approved by Licensor.
Ribozymes For Products shall mean Ribozymes used in Semi-finished Products, Products or Licensed Services.
Product shall mean products designed, developed, and sold against a Target Disease by Licensee (or Licensor in the event of a reversion), or an Affiliate, Collaborator or Corporate Partner and which is generally in finished form and ready for end use without further substantial chemical alteration.
Licensed Services shall mean any service within the Field, other than the development, production and sale of a Product or Semi-finished Product, which is performed for a third-party by Licensee, an Affiliate or a sublicensee hereunder, and which includes use of a Semi-finished Product or Product or any invention, method, process, procedure or technology which is included, in whole or in part, in Licensor Technology.
Target Disease shall mean any one of the human diseases conditions for which a Work Plan has been approved by Licensor.
Semi-finished Product shall mean ribozymes or products which have not been substantially transformed by Licensee or an Affiliate into a Product and which are transferred to a Corporate Partner in an arms length transaction for the purpose of sales of Products and/or Licensed Services.
IPSCIO Record ID: 300745
For the Manufacturing License, Licensor grants a non-exclusive license under Licensor Technology solely for the purpose of Manufacturing the Licensed Product for the Licensee Territory and Licensee grants Licensor a non-exclusive license under Licensee Technology to Manufacture the Licensed Product.
Antisense Product means a single-stranded oligonucleotide or analog thereof having a specific sequence that inhibits protein synthesis at the nucleic acid level by specifically binding to the sequence of a messenger or viral ribonucleic acid (RNA) by base-pairing, thus causing selective inhibition of gene expression.
The patents include, but are not limited to; RNA interference is mitigated by 21 and 22nt small RNAs; RNA interference mediating small RNA molecules; RNA sequence-specific mediators of RNA interference; and, Inhaled treatment for RSV.
RSV is a highly contagious virus that causes infections in both the upper and lower respiratory tract.
IPSCIO Record ID: 204355
In the original restated license, Licensor grants a world-wide exclusive license under Licensed Patents and Licensed Know-How, to make, use, offer to sell, sell and import Licensed Products in the Exclusive Licensed Field.
The licensed know-how includes chemical structures, manufacturing methods and Algorithms, object code, source code and any other embodiments of methods or processes useful for predicting the melting temperature of MGB Oligonucleotides, whether patented, copyrighted, or not.